Dr. Joshua Rosenblat is a psychiatrist and clinician-researcher at the Mood Disorders Psychopharmacology Unit (MDPU) at Toronto Western Hospital. Dr. Rosenblat completed his Bachelor of Science degree at the University of Toronto before his medical degree at the Schulich School of Medicine at the University of Western Ontario (UWO). He returned to the University of Toronto to complete his residency training in psychiatry where he also served as the chief resident of the Clinician-Scientist Program (CSP). Throughout medical school and residency, he conducted clinical research on novel pharmacological interventions for mood disorders. He then completed his graduate training in the department of pharmacology and toxicology, studying the effects of ketamine for depression.

Dr. Rosenblat’s clinical focus is on mood disorders, with specialized expertise in pharmacological treatments. He conducts clinical trials to identify and evaluate novel psychopharmacological interventions for mood disorders that may substantially improve patient outcomes. Specific research programs currently underway include clinical trials evaluating ketamine and psilocybin assisted therapy for bipolar and unipolar depression with federal funding for these programs. He has authored and co-authored over 200 journal articles and textbook chapters in prestigious journals, such as the New England Journal of Medicine, JAMA Psychiatry, the American Journal of Psychiatry and the Lancet. He has received numerous local, national and international grants and awards for his research in mood disorders.